Dalsy Ibuprofen

Dalsy is a well-known pharmaceutical brand in Spain, primarily recognized for its ibuprofen oral suspension designed for children. Originally developed by the Spanish pharmaceutical company Madaus, the brand has deep roots in the local healthcare market.

Today, Dalsy is part of the global portfolio of Mylan, which merged with Upjohn (a division of Pfizer) to form Viatris in 2020. This transition has consolidated the brand under a major American healthcare corporation. Production primarily takes place in specialized pharmaceutical facilities in Spain to serve the local and European markets, ensuring high quality and regulatory compliance.